Please login to the form below

Not currently logged in
Email:
Password:

Quintiles joins forces with Archimedes to quantify healthcare decisions

Biopharmaceutical services company will use Archimedes' healthcare modeling technology

Quintiles has formed a partnership with a San Francisco-based healthcare modeling company to offer a new range of services aimed at reducing the time and expense of bring new therapies to market.

The biopharmaceutical services company will use Archimedes's technology to capture “predictive simulations from real-world research”, said global head of integrated clinical services Rick Sax.

“Turning data into insights will allow customers to make faster, better decisions across the product lifecycle and increase their probability of success,” he added.

Quintiles will promote and provide access to Archimedes' ARCHeS Innovator technology, which enables users to run clinically realistic virtual trials.

Mika Newton, vice president, ARCHeS and consulting business leader for Archimedes, said: “Biopharma companies are under enormous pressure to maximise the efficiency and strategic positioning of products they are developing and marketing.

“This partnership between Archimedes and Quintiles makes advanced simulation modeling and premier medical evidence accessible and fully integrated into customers' clinical research and commercial activities.”

Archimedes is a spin-off of the US managed care consortium Kaiser Permanente and has worked with the FDA, Novo Nordisk and Bristol-Myers Squibb.

2nd April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics